UBS Group
CLOV icon

UBS Group’s Clover Health Investments CLOV Stock Holding History

UBS Group’s Portfolio CLOV Stock Details CLOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-44,600
Closed -$594K – 9588
2021
Q2 		$594K Buy
+44,600
New +$438K ﹤0.01% 4596

Other funds holding CLOV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

UBS Group's CLOV Position: Q2 2026 in Review

UBS Group reduced its Clover Health Investments (CLOV) stake by 77% in Q2 2026, selling an estimated $4.61M and leaving 409,450 shares worth $2.15M. The position accounts for ﹤0.01% of the portfolio, ranked #5057.

UBS Group first reported a position in CLOV in Q2 2020 and has held it in 25 quarters since. The position peaked at $6.98M in Q3 2025. 227 funds tracked by Wall St. Rank hold CLOV as of Q2 2026.

  • UBS Group held 409,450 shares of Clover Health Investments worth $2.15M as of Q2 2026.
  • UBS Group sold 1,358,349 Clover Health Investments shares in Q2 2026, an estimated $4.61M.
  • Clover Health Investments made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #5057 holding.
  • UBS Group first reported a position in Clover Health Investments in Q2 2020 and has held it in 25 quarters since.
  • UBS Group's Clover Health Investments position peaked at $6.98M in Q3 2025.
  • 227 funds tracked by Wall St. Rank held Clover Health Investments as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.